Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Fortrea (Nasdaq: FTRE), a global contract research organization, has announced the granting of inducement awards to a new employee. The award consists of 75,000 restricted stock units (RSUs) that will vest over three years in equal annual installments, beginning September 12, 2026.
The RSUs are granted under the Company's Amended and Restated 2025 Inducement Award Plan and comply with Nasdaq Listing Rule 5635(c)(4), serving as an employment inducement for the new hire.
Fortrea (Nasdaq: FTRE), un'organizzazione globale di ricerca clinica, ha annunciato l'assegnazione di premi di incentivazione a un nuovo dipendente. Il premio consiste in 75.000 unità azionarie vincolate (RSU) che matureranno in tre anni mediante rate annuali uguali, a partire dal 12 settembre 2026.
Le RSU sono concesse ai sensi del Piano di Incentivi 2025 della Società, modificato e riformulato, e sono conformi alla Nasdaq Listing Rule 5635(c)(4), costituendo un incentivo all'assunzione per il nuovo assunto.
Fortrea (Nasdaq: FTRE), una organización global de investigación por contrato, ha anunciado la concesión de premios de inducción a un nuevo empleado. El premio consta de 75,000 unidades de acciones restringidas (RSU) que se consolidarán durante tres a?os en cuotas anuales iguales, a partir del 12 de septiembre de 2026.
Las RSU se otorgan conforme al Plan de Premios de Inducción 2025 Modificado y Reformulado de la Compa?ía y cumplen con la Regla 5635(c)(4) de Nasdaq, sirviendo como un incentivo de empleo para la nueva contratación.
Fortrea (???: FTRE), ??? ?? ?? ??? ?? ???? ?? ??? ????? ??????. ??? 75,000 ???????(RSU)?? ????, 3? ?? ?? ??? ??? vesting?? ??? 2026? 9? 12????.
RSU? ??? 2025? ?? ? ???? ?? ?? ??? ?? ???? Nasdaq ??? ?? 5635(c)(4)? ???? ?? ??? ?? ?? ????? ???.
Fortrea (Nasdaq: FTRE), une organisation mondiale de recherche sous contrat, a annoncé l'octroi de primes d'incitation à un nouvel employé. La prime se compose de 75 000 unités d'actions restreintes (RSU) qui vestent sur trois ans par tranches annuelles égales, à compter du 12 septembre 2026.
Les RSU sont accordées en vertu du plan d'attribution d'incitation 2025 modifié et révisé de la société et respectent la règle de cotation Nasdaq 5635(c)(4), servant d'incitation à l'emploi pour le nouvel embauché.
Fortrea (Nasdaq: FTRE), ein globales Vertragsforschungsunternehmen, hat die Gew?hrung von Anreiz-Boni an einen neuen Mitarbeiter bekannt gegeben. Der Zuschuss besteht aus 75.000 Restricted Stock Units (RSUs), die über drei Jahre hinweg in gleichen j?hrlichen Tranchen vesten, beginnend am 12. September 2026.
Die RSUs werden gem?? dem überarbeiteten und erg?nzten Inducement Award Plan 2025 des Unternehmens gew?hrt und erfüllen die Nasdaq Listing Rule 5635(c)(4), und dienen als Anreiz für die Einstellung des neuen Mitarbeiters.
Fortrea (????? ??????: FTRE)? ??? ????? ????? ??????? ??????? ????? ?? ??? ????? ????? ????? ????. ????? ??????? ?? 75,000 ???? ???? ????? (RSUs) ???? vesting ??? ??? ???? ????? ??? ????? ????? ???????? ????? ?? 12 ?????? 2026.
????? RSUs ????? ??? ??? ??????? ???? 2025 ??????? ??????? ??????? ?????? ?????? ?????? Nasdaq Listing Rule 5635(c)(4)? ????? ????? ????? ???????? ??????.
贵辞谤迟谤别补(纳斯达克代码:贵罢搁贰),是一家全球性的合同研究机构,宣布向一名新员工授予诱导性奖励。该奖励包括75,000单位受限股票单元(搁厂鲍蝉),将于叁年内按每年等额分期归属,首次在2026年9月12日归属。
RSUs 根据公司修订并重述的2025诱导奖励计划授予,并符合 Nasdaq 上市规则 5635(c)(4),作为对新员工的雇佣诱导。
- None.
- None.
DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on September 12, 2025, to one newly hired employee. The award consisted of 75,000 RSUs that vest in three equal annual installments starting September 12, 2026, subject to the employee’s continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company’s Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, [email protected]
Sue Zaranek (Media) – 919-943-5422, [email protected]
Kate Dillon (Media) – 646-818-9115, [email protected]
